Antihypertensive & COVID-19: The Verdict of Review and Meta-Analysis

[updated May 18] What biochemistry facts and clinical outcomes really say.

[Modified and Redesigned] Image by Clker-Free-Vector-Images from Pixabay

Prior studies and meta-analyses have shown that medical comorbidities — like diabetes, hypertension, cardiac and pulmonary diseases — increase the risk of disease progression and mortality from COVID-19.